PMGC Holdings Inc.
ELABHealthcareNASDAQBiotechnology · Last scanned Oct 24, 2026
Scan Results
Daily timeframePMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. The $2.2M market capitalization puts ELAB squarely in micro-cap range for its industry. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Market Cap
$2.2M
Beta
-0.27
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-1778.40
EPS (Fwd)
—
ROE
-105.2%
ROA
-33.0%
Cash
$19.0M
Total Debt
$14.2M
Free CF
-$4.1M
52W Change
-99.8%
Annual Financials
Cash vs Debt
Where ELAB stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, ELAB finished 82.87% below its 150-day moving average ($16.52) and 94.29% below its 200-day moving average ($49.59). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ELAB overbought or oversold?
At the October 20, 2026 close, ELAB's RSI(14) was 19.8, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
PMGC Holdings Inc. holds $19.0M in cash against $14.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$4.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -105.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $766K (2022) to $590K (2025), a 23% decline worth watching.
The relatively low beta of -0.27 suggests ELAB is a less volatile holding compared to the broader index. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence PMGC Holdings Inc.'s trajectory.